Transaction fees drive MedAdvisor growth

The introduction of new transaction fees is contributing to revenue growth for MedAdvisor Solutions  Transaction fees for vaccinations and “services associated with Project STOP” are already boosting medication management software provider, MedAdvisor’s revenue.  In an update to the Australian Securities Exchange (ASX), the company reported “strong revenue growth” for the quarter ending 31 March.  

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous TGA seizes 500k illegally imported vapes
Next How should OTC analgesics be displayed?